MHMette Hartlev

Mette Hartlev

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mette Hartlev has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Health Data-Driven Research — Time for a Stronger Human Rights Governance Structure?

    by Mette Hartlev

    This article is inspired by Herman Nys’s tireless academic insistence on the importance of human rights and fundamental ethical principles in biomedicine. It examines the evolving landscape of data-driven health research in Europe, using a recent Danish case involving large-scale access to electronic health records as a point of departure. The article explores whether existing European regulatory frameworks adequately safeguard the rights and freedoms of data subjects in contemporary research contexts. The article argues that while data-driven research is often justified by public interest, this concept remains underdefined and insufficiently aligned with patients’ and citizens’ expectations. It concludes that current legal instruments may not fully reflect the broader catalogue of human rights at stake, including dignity, integrity, and protection against discrimination. The article calls for a recalibration of safeguards and governance mechanisms, including stronger ethical review and participatory structures, to ensure that health data research respects both individual rights and collective imaginaries of technological development.

  • Comparative Review of National Regulatory Frameworks in the Context of Secondary Use of Data for Research Across Europe

    by Olga Tzortzatou-Nanopoulou, Alexandra Ziaka, Carla Barbosa, Gauthier Chassang, Aliuska Duardo-Sánchez, Silja Elunurm, Christine Dalebø Gjerdevik, Radek Halouzka, Mette Hartlev, Ragnhild Angell Holst, et al.


  • Open Access

    The life and death of confidentiality: a historical analysis of the flows of patient information

    by Sarah Wadmann, Mette Hartlev, Klaus Hoeyer

    Health data can contain sensitive information. People who consult a doctor seek help on issues that matter to them: they typically expect some form of confidentiality. However, the notion and practices of confidentiality have changed dramatically over time. In this article, we trace the history of confidentiality in the Danish healthcare system, which has one of the world’s most integrated patient information infrastructures. Building on an analysis of legal and political documents dating back to the late seventeenth century, we show that confidentiality originated as a social phenomenon that helped build trust in healthcare professionals and gradually developed into an idiom of citizens rights. Lately, confidentiality has given way to more technocratic forms of data protection. As the political, legal and technological reality, which the idea of confidentiality once referred to, has radically changed, we argue that confidentiality has become what Ulrik Beck has called a ‘zombie category’—a notion that lives on even if its content has passed away. If confidentiality has become a zombie concept, we suggest it is time to discuss what may take its place so that patient interests are protected in the current political economy of health data.


  • Health Disparities and New Health Technologies – A Patients’ and Human Rights Perspective

    by Mette Hartlev

    The human right to health requires that everyone should have equal opportunities to enjoy the highest attainable standard of health. In practice, this is hard to achieve, as health is shaped by social determinants. This article explores the impact personalized medicine and use of big data may have on health disparities. New health technologies offer a lot of hope for more individual and better health promotion and care, which potentially could be beneficial for the most deprived. However, there are also concerns that not all population groups will profit equally from this new population-based medicine, and that new digital health technologies will maintain – or even reinforce – existing health disparities. This article suggests using insights from poverty studies combined with a patients’ and human rights-based approach to ensure that the most deprived are not left behind in the application of new health technologies.


  • Open Access

    Balancing of Individual Rights and Research Interests in Danish Biobank Regulation

    by Mette Hartlev

    Denmark offers very good opportunities for biobank research. There is a vast number of well-structured and comprehensive collections of biological material, which in combination with a ‘research generous’ legislation provides an excellent environment for biobank research. However, both the Danish biobank landscape and the regulatory environment is rather complex. In contrast to a number of other countries, there is no specific biobank act in Denmark. Instead, various regulatory regimes interact, which makes it challenging to navigate in the legal landscape. It is also rather non-transparent for the individuals, from whom samples have been collected, what samples are used for, and how they can influence the use of samples for research. With the GDPR and the Danish Data Protection Act it seems that research participants’ rights have been slightly weakened in Danish law. However, it is argued, that the GDPR has the potential to ensure more awareness of research participants right against the societal and scientific interest in research.


  • Right to Hospital Care and Prioritisation from a Law and Politics Perspective – The Experiences of Norway and Denmark

    by Henriette Sinding Aasen, Mette Hartlev, Anne-Mette Magnussen

    As members of the Nordic family of welfare states, both Norway and Denmark are characterised by universal access to health care. Legislation and individual rights have increasingly been used as tools to promote and protect patients' equal access to health care services. At the same time both countries are struggling with increasing health care expenditures, waiting lists and a demand to prioritise health care resources in light of new and expensive treatment options. This calls for political space to adjust prioritisation policies and procedures. The article analyses the regulation of access to hospital care in Norway and Denmark, from a law and politics perspective. We explore similarities and differences between the two countries with respect to the objectives of the regulation and formulation of the right to hospital care, and how the interplay between law and politics – and juridification and politicisation – is expressed and managed in the regulation. We conclude that even though there are differences between the two countries in the extent of juridification, the regulation in both countries still leaves room for continued political governance of issues related to the prior itisation of health care services.


    • 1 June 2010
      • Vol. 17  (3) , 279-94

    Recent developments in Nordic health law.

    by Elisabeth Rynning, Oddný Mjöll Arnardottir, Mette Hartlev, Henriette Sinding Aasen, Sirpa Soini

    The five Nordic countries--Denmark, Finland, Iceland, Norway and Sweden--share a considerable part of their cultural and historical heritage. They have collaborated closely in their development of legislation during most of the 20th century and are also all traditional welfare states, but nevertheless demonstrate a surprising degree of variety in the area of health law. The Nordic Network for Research in Biomedical Law was founded in 2006, with the aim to promote intra-disciplinary collaboration and stimulate comparative Nordic research in this field of law. Exchange of information on recent legal developments has been a recurrent point on the agenda at the Network meetings.